Products
Data
Feature
Plans
Request Demo
Sign Up for Free
Blog
Valuable Targets
Advanced Tech.
Pharmaceutical Insights
Navigate pharmaceutical trends with our insights on targets, institutional pipelines, clinical advances, and new drugs.
Recent blog posts
Latest Hotspot
8 min read
GPR22 Biologics Sequence Review Report 2026: G protein-coupled receptor 22 Similarity and Patent-Risk Signals
6 August 2026
A Biology Modality MCP review of GPR22 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
GPR20 Biologics Sequence Review Report 2026: G protein-coupled receptor 20 Similarity and Patent-Risk Signals
6 August 2026
A Biology Modality MCP review of GPR20 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
GPR18 Biologics Sequence Review Report 2026: N-arachidonyl glycine receptor Similarity and Patent-Risk Signals
6 August 2026
A Biology Modality MCP review of GPR18 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
GPR176 Biologics Sequence Review Report 2026: G protein-coupled receptor 176 Similarity and Patent-Risk Signals
6 August 2026
A Biology Modality MCP review of GPR176 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
GPR17 Biologics Sequence Review Report 2026: Uracil nucleotide/cysteinyl leukotriene receptor Similarity and Patent-Risk Signals
6 August 2026
A Biology Modality MCP review of GPR17 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
GPR161 Biologics Sequence Review Report 2026: G protein-coupled receptor 161 Similarity and Patent-Risk Signals
6 August 2026
A Biology Modality MCP review of GPR161 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
GPR157 Biologics Sequence Review Report 2026: G protein-coupled receptor 157 Similarity and Patent-Risk Signals
6 August 2026
A Biology Modality MCP review of GPR157 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
GPR151 Biologics Sequence Review Report 2026: G protein-coupled receptor 151 Similarity and Patent-Risk Signals
6 August 2026
A Biology Modality MCP review of GPR151 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
GPR146 Biologics Sequence Review Report 2026: G protein-coupled receptor 146 Similarity and Patent-Risk Signals
6 August 2026
A Biology Modality MCP review of GPR146 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
GPR142 Biologics Sequence Review Report 2026: G protein-coupled receptor 142 Similarity and Patent-Risk Signals
6 August 2026
A Biology Modality MCP review of GPR142 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
8 min read
GPR135 Biologics Sequence Review Report 2026: G protein-coupled receptor 135 Similarity and Patent-Risk Signals
6 August 2026
A Biology Modality MCP review of GPR135 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
GPR119 Biologics Sequence Review Report 2026: Glucose-dependent insulinotropic receptor Similarity and Patent-Risk Signals
6 August 2026
A Biology Modality MCP review of GPR119 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
<
1
<<
254
255
256
257
258
>>
1670
>